Alexandru Dumitrescu

Alexandru Dumitrescu

Auto-generated profile, based on publicly available information

Alexandru Dumitrescu

Department of Computer Science, Aalto University , Espoo 02150, Finland

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2023 in Bioinformatics
Verified
Journal Article
Open access
PDF file
DKDani Korpela
Dani Korpela
EJEmmi Jokinen
Emmi Jokinen
ADAlexandru Dumitrescu
Alexandru Dumitrescu
JHJani Huuhtanen
Jani Huuhtanen
SMSatu Mustjoki
Satu Mustjoki
HLHarri Lähdesmäki
Harri Lähdesmäki
T cells play an essential role in adaptive immune system to fight pathogens and cancer but may also give rise to autoimmune diseases. The recognition of a peptide–MHC (pMHC) complex by a T cell receptor (TCR) is required to elicit an immune response. Many machine learning models have been developed to predict the binding, but generalizing predictions to pMHCs outside the training data remains challenging. We have developed a new machine learning model that utilizes information about the TCR from both α and β chains, epitope sequence, and MHC. Our method uses ProtBERT embeddings for the amino acid sequences of both chains and the epitope, as well as convolution and multi-head attention architectures. We show the importance of each input feature as well as the benefit of including epitopes with only a few TCRs to the training data. We evaluate our model on existing databases and show that it compares favorably against other state-of-the-art models. https://github.com/DaniTheOrange/EPIC-TRACE.

7 December 2022 in Bioinformatics
Verified
Journal Article
Open access
PDF file
EJEmmi Jokinen
Emmi Jokinen
ADAlexandru Dumitrescu
Alexandru Dumitrescu
JHJani Huuhtanen
Jani Huuhtanen
VGVladimir Gligorijević
Vladimir Gligorijević
SMSatu Mustjoki
Satu Mustjoki
HLHarri Lähdesmäki
Harri Lähdesmäki
T cells use T cell receptors (TCRs) to recognize small parts of antigens, called epitopes, presented by major histocompatibility complexes. Once an epitope is recognized, an immune response is initiated and T cell activation and proliferation by clonal expansion begin. Clonal populations of T cells with identical TCRs can remain in the body for years, thus forming immunological memory and potentially mappable immunological signatures, which could have implications in clinical applications including infectious diseases, autoimmunity and tumor immunology. We introduce TCRconv, a deep learning model for predicting recognition between TCRs and epitopes. TCRconv uses a deep protein language model and convolutions to extract contextualized motifs and provides state-of-the-art TCR-epitope prediction accuracy. Using TCR repertoires from COVID-19 patients, we demonstrate that TCRconv can provide insight into T cell dynamics and phenotypes during the disease. TCRconv is available at https://github.com/emmijokinen/tcrconv. Supplementary data are available at Bioinformatics online.

1 June 2023 in Bioinformatics
Verified
Journal Article
Open access
PDF file
ADAlexandru Dumitrescu
Alexandru Dumitrescu
EJEmmi Jokinen
Emmi Jokinen
APAnja Paatero
Anja Paatero
JKJuho Kellosalo
Juho Kellosalo
VPVille O Paavilainen
Ville O Paavilainen
HLHarri Lähdesmäki
Harri Lähdesmäki
Motivation: Signal peptides (SPs) are short amino acid segments present at the N-terminus of newly synthesized proteins that facilitate protein translocation into the lumen of the endoplasmic reticulum, after which they are cleaved off. Specific regions of SPs influence the efficiency of protein translocation, and small changes in their primary structure can abolish protein secretion altogether. The lack of conserved motifs across SPs, sensitivity to mutations, and variability in the length of the peptides make SP prediction a challenging task that has been extensively pursued over the years. Results: We introduce TSignal, a deep transformer-based neural network architecture that utilizes BERT language models and dot-product attention techniques. TSignal predicts the presence of SPs and the cleavage site between the SP and the translocated mature protein. We use common benchmark datasets and show competitive accuracy in terms of SP presence prediction and state-of-the-art accuracy in terms of cleavage site prediction for most of the SP types and organism groups. We further illustrate that our fully data-driven trained model identifies useful biological information on heterogeneous test sequences. Availability and implementation: TSignal is available at: https://github.com/Dumitrescu-Alexandru/TSignal.

24 May 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
EJEmmi Jokinen
Emmi Jokinen
ADAlexandru Dumitrescu
Alexandru Dumitrescu
JHJani Huuhtanen
Jani Huuhtanen
VGVladimir Gligorijević
Vladimir Gligorijević
SMSatu Mustjoki
Satu Mustjoki
HLHarri Lähdesmäki
Harri Lähdesmäki
We introduce TCRconv, a deep learning model for predicting recognition between T-cell receptors and epitopes. TCRconv uses a deep protein language model and convolutions to extract contextualized motifs and provides state-of-the-art TCR-epitope prediction accuracy. Using TCR repertoires from COVID-19 patients, we demonstrate that TCRconv can provide insight into T-cell dynamics and phenotypes during the disease.

28 June 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
DKDani Korpela
Dani Korpela
EJEmmi Jokinen
Emmi Jokinen
ADAlexandru Dumitrescu
Alexandru Dumitrescu
JHJani Huuhtanen
Jani Huuhtanen
SMSatu Mustjoki
Satu Mustjoki
HLHarri Lähdesmäki
Harri Lähdesmäki
T cells play an essential role in adaptive immune system to fight pathogens and cancer but may also give rise to autoimmune diseases. The recognition of a peptide-MHC (pMHC) complex by a T cell receptor (TCR) is required to elicit an immune response. Many machine learning models have been developed to predict the binding, but generalizing predictions to pMHCs outside the training data remains challenging. We have developed a new machine learning model that utilizes information about the TCR from both α and β chains, epitope sequence, and MHC. Our method uses ProtBERT embeddings for the amino acid sequences of both chains and the epitope, as well as convolution and multi-head attention architectures. We show the importance of each input feature as well as the benefit of including epitopes with only a few TCRs to the training data. We evaluate our model on existing databases and show that it compares favorably against other state-of-the-art models.

1 August 2026 in Bioinformatics
Verified
Journal Article
Open access
DKDani Korpela
Dani Korpela
ADAlexandru Dumitrescu
Alexandru Dumitrescu
MSMartin Stražar
Martin Stražar
RLRui Li
Rui Li
RXRamnik J Xavier
Ramnik J Xavier
HLHarri Lähdesmäki
Harri Lähdesmäki
Motivation: Peptide-MHC II binding drives adaptive immunity, yet discovery of novel binder peptides remains challenging due to open binding grooves of MHC-II that accommodate variable-length peptides. While discriminative models perform well, they are unfeasible for generation via enumeration due to vast peptide space (2013≈8×1016 for peptides of length 13 amino acids). Generative AI approaches could accelerate binder design to enable vaccines targeted to particular MHC-II alleles or optimize other peptide chemical properties. Results: We introduce PepGen, the first protein language model for MHC II peptide generation building on Generalized Language Modeling. PepGen conditions on alleles, arbitrary partial peptides including putative TCR-interacting motifs, and continuous binding affinity. Across multiple benchmarks including infilling and de novo generation, PepGen outperformed frequency sampling, Gibbs clustering, and autoregressive baselines. Adjusted log-probabilities enable good classification performance. Experimental validation confirmed that the SARS-CoV-2 peptide TEGALNTPKDHIGTR binding the HLA-DQA101:03-DQB106:03 allele can be redesigned to bind the HLA-DQA101:02-DQB105:02 allele. PepGen generated three putative TCR-motif-preserving binders gaining up to 70% of original MFI. Overall, PepGen provides scalable, motif-constrained MHC II peptide redesign and de novo generation, validated through thorough benchmarks and functional assays. Availability and implementation: Code and Data are available at https://github.com/DaniTheOrange/PepGen.